A phase II trial of oral UFT plus cisplatin (CDDP) in patients with non-small cell lung cancer (NSCLC)
- 1 March 2001
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 31 (2-3) , 285-293
- https://doi.org/10.1016/s0169-5002(00)00183-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Pilot study of UFT combined with 5 consecutive days cisplatin in non-small cell lung cancerLung Cancer, 1997
- 56 A Phase II trial of UFT plus cisplatin in patients with advanced non-small cell lung cancerLung Cancer, 1997
- A phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable nonsmall cell lung cancerCancer, 1995
- A Study of Oral Etoposide, Infusional Cisplatin, and Infusional 5-Fluorouracil for Locally Advanced or Metastatic Non-Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 1992
- In vivo comparative therapeutic study of optimal administration of 5-fluorouracil and cisplatin using a newly established HST-1 human squamous-carcinoma cell lineCancer Chemotherapy and Pharmacology, 1992
- A study of infusional cisplatin and infusional fluorouracil for locally advanced or metastatic non-small-cell lung cancer: a Mid-Atlantic Oncology Program study.Journal of Clinical Oncology, 1991
- Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group BCancer, 1991
- Alternating sequential cisplatin (CDDP) and 5-fluorouracil (FU) in continuous infusion (CI) for advanced bronchogenic carcinomaLung Cancer, 1991
- Toxicity and response criteria of the Eastern Cooperative Oncology GroupAmerican Journal of Clinical Oncology, 1982
- One-Sample Multiple Testing Procedure for Phase II Clinical TrialsPublished by JSTOR ,1982